In a week when several major outlets turned their attention to the same discovery, researchers in Australia, among them scientists at the University of Sydney, have proposed that some depression may be rooted less in mood alone than in the body's own timekeeping. They call this possibility circadian depression, a form in which the internal clock that governs sleep and waking appears to be out of step. The claim that this subtype responds poorly to standard antidepressants carries weight, since those medicines are often the first thing offered to a person in distress. Yet the story is still bei
Researchers Identify 'Circadian' Subtype of Depression Linked to Body Clock Disruption
A disrupted body clock may mark out a distinct kind of depression
Mark
So what is actually new here?
Mimi
Researchers in Australia, including scientists at the University of Sydney, say they have identified a subtype they call circadian depression, linked to a disrupted body clock.
Mark
Why would that matter to someone being treated now?
Mimi
Because the reports say this type responds poorly to antidepressants. That could change which treatments are tried for some patients.
Luke
Careful with "could." What we have are headlines. We don't have the study's design in front of us.
Mark
What's missing, specifically?
Luke
Sample size, how the clock disruption was measured, and how much worse the drug response was. None of that is in what we've seen.
Mimi
That's fair. The sleep angle is the hook, though. The Times framed it as sleep habits possibly indicating a type of depression.
Mark
And the "millions" figure?
Luke
That's NewsNation's headline. I can't tell you where it comes from or whether it's the researchers' estimate.
Mimi
So the direction is interesting, but the scale is unconfirmed.
Luke
Right. Replication and trials of body-clock treatments are what would turn this from a lead into practice.
O Pulso
- A cluster of headlines from NewsNation, The New York Times, The Guardian and New Scientist has pushed a single claim into public view within days.
- The proposed 'circadian depression' challenges the assumption that mood disorders are primarily a matter of brain chemistry and treatable by standard drugs.
- The most unsettling implication is that a sizable group of patients may be getting treatments that do little for them, and the headlines hint at millions affected.
- Key details of sample size, measurement methods and the scale of poor response remain outside the headlines, leaving clinicians and families without firm numbers.
- The finding is now in the hands of independent researchers and future clinical trials, and nothing about diagnosis or prescribing will shift until those tests come back.
In a week when several major outlets turned their attention to the same discovery, researchers in Australia, among them scientists at the University of Sydney, have proposed that some depression may be rooted less in mood alone than in the body's own timekeeping. They call this possibility circadian depression, a form in which the internal clock that governs sleep and waking appears to be out of step. The claim that this subtype responds poorly to standard antidepressants carries weight, since those medicines are often the first thing offered to a person in distress. Yet the story is still being told largely through its headlines, and the fuller accounts of how the researchers measured and defined this group remain for the wider scientific world to examine.
A cluster of headlines appeared together this week, all pointing to one finding from Australia. Researchers, including scientists at the University of Sydney, say they have identified a new subtype of depression tied to disruption of the body's circadian clock. They are calling it "circadian depression," a label that puts the internal timekeeper, rather than mood alone, at the center of the condition.
The coverage carries two central claims. The New York Times framed the finding around sleep habits as a possible sign of this type of depression. New Scientist reported that the form responds poorly to antidepressants, the medications most often used as a first step. If that holds, it could change how some patients are treated.
The headlines are less clear on the particulars. Questions of how many people might be affected, how many participants were studied, and how body clock disruption was measured remain open in this coverage. Those answers belong to the full reports and the underlying study.
For now, the message is that disrupted circadian rhythms may mark out a distinct group of people with depression who may not benefit much from the most common drugs. Independent replication and trials of body-clock treatments are what will decide whether this becomes a change in practice or stays a promising lead.
A cluster of headlines appeared together on Google News this week, all pointing to the same finding: researchers in Australia say they have identified a new subtype of depression tied to disruption of the body's circadian clock. The outlets carrying the story include NewsNation, The New York Times, The Guardian and New Scientist, along with a release from the University of Sydney.
The work comes from Australian researchers, among them scientists at the University of Sydney. The subtype they describe is being called "circadian depression," a label that places the body clock, rather than mood alone, at the center of the condition.
The headlines carry two claims. The first is that sleep habits may indicate this type of depression, which is how The New York Times framed it. The second, in New Scientist's wording, is that the newly identified form responds poorly to antidepressants. If that holds, it bears directly on how some patients are treated, since standard antidepressants are the usual first approach.
NewsNation's headline raised the question of scale, suggesting the subtype could affect millions of people. The material available here does not say how many people that is, how the researchers arrived at the estimate, or how the subtype was defined in practice. Those details sit in the full reports and the underlying study, which are not reproduced here.
The same is true of the method. The headlines do not say how many participants were studied, what measurements were used to track body clock disruption, or how poor a response to antidepressants was compared with other patients. Readers should treat the headline-level claims as a starting point rather than a complete account.
What can be said is that several major outlets, working from Australian research, converged on one message: disrupted circadian rhythms may mark out a distinct group among people with depression, and that group may not benefit much from the drugs most commonly prescribed.
What to watch next is independent replication of the finding by other research teams, and clinical trials testing treatments aimed at the body clock. Until those arrive, the idea is a promising lead and not yet a reason to change how depression is diagnosed or treated.
Citações Notáveis
Newly identified 'circadian depression' responds poorly to antidepressants.— New Scientist headline
Quer a matéria completa?
Leia o original em Google News ↗
Science & Space